We found a match
Your institution may have rights to this item. Sign in to continue.
- Title
Immune Cell and Biochemical Biomarkers in Advanced Laryngeal Cancer.
- Authors
Jotic, Ana; Milovanovic, Jovica; Savic-Vujovic, Katarina; Radin, Zorana; Medic, Branislava; Folic, Miljan; Pavlovic, Bojan; Vujovic, Aleksandar; Dundjerovic, Dusko
- Abstract
Objective: The aim of this study was to evaluate cell and biochemical biomarkers and establish their prognostic value in patients with advanced laryngeal cancer. Material and Methods: A prospective study included 52 patients with advanced laryngeal carcinoma surgically treated at the tertiary referral center. Tumor tissue was immunohistochemically stained for T-cell markers (CD4 and CD8), and levels of cytokines (IL-6 and IL-8) and C-reactive protein were analyzed from blood samples. Results: Overall 3-year survival (OS) of patients included in the study was 69.2% and the disease specific survival (DSS) 72.5%. Higher expression of CD4+ and CD8+ were significant prognostic factors with positive impact on both OS and DSS in univariate analysis, but not in multivariate analysis. Levels of IL-8 were a significant predictor of 3-year OS and DSS survival in patients with advanced laryngeal cancer but not levels of IL-6 and CRP values. Conclusion: Though high expression of CD4 and CD8 were demonstrated in the tumor tissue, but their prognostic role was not established. Higher values of IL-8 proved to be significant negative predictor of DSS. This could further collaborate the inclusion of combination of biomarkers in assessment of favorable treatment choice in patients with advanced laryngeal carcinoma.
- Subjects
LARYNGEAL cancer; CANCER patients; BIOMARKERS; PROGNOSIS; OVERALL survival
- Publication
Dose-Response, 2022, Vol 20, Issue 3, p1
- ISSN
1559-3258
- Publication type
Article
- DOI
10.1177/15593258221115537